Here, we sought to analyze the genomic architecture, bone marrow morphology as well as immunophenotypes of patients with DDX41 mutated AML, MDS and MPN to explore possible genotype–phenotype correlations between individuals with these DDX41 related hematologic malignancies. Here, DDX41 is linked to myeloproliferative disorder.